X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiac & cardiovascular systems (103) 103
humans (81) 81
index medicus (77) 77
male (72) 72
female (69) 69
cardiovascular (67) 67
middle aged (64) 64
aged (54) 54
treatment outcome (53) 53
abridged index medicus (46) 46
heart attacks (42) 42
cardiology (38) 38
mortality (36) 36
stents (36) 36
angioplasty (35) 35
time factors (32) 32
cardiology and cardiovascular medicine (31) 31
coronary vessels (30) 30
percutaneous coronary intervention (29) 29
transluminal angioplasty (29) 29
heart attack (28) 28
coronary angiography (27) 27
stent (27) 27
follow-up studies (26) 26
prospective studies (25) 25
myocardial infarction - therapy (24) 24
cardiac patients (23) 23
electrocardiography (23) 23
internal medicine (23) 23
outcomes (23) 23
angioplasty, balloon, coronary (21) 21
medicine (21) 21
original paper (20) 20
risk factors (20) 20
care and treatment (19) 19
drug-eluting stents (19) 19
myocardial infarction - mortality (19) 19
trial (18) 18
intervention (17) 17
patient outcomes (17) 17
analysis (16) 16
medical colleges (16) 16
primary angioplasty (16) 16
angiography (15) 15
impact (15) 15
abciximab (14) 14
absorbable implants (14) 14
everolimus (14) 14
stroke (14) 14
thrombosis (14) 14
acute coronary syndromes (13) 13
implantation (13) 13
myocardial infarction (13) 13
myocardial infarction - diagnosis (13) 13
reperfusion (13) 13
aged, 80 and over (12) 12
ischemia (12) 12
medical imaging (12) 12
myocardial infarction - surgery (12) 12
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (12) 12
prognosis (12) 12
acute myocardial-infarction (11) 11
clinical trials (11) 11
coronary artery bypass (11) 11
prosthesis design (11) 11
registries (11) 11
risk (11) 11
sirolimus - analogs & derivatives (11) 11
adult (10) 10
cardiovascular disease (10) 10
coronary artery disease - therapy (10) 10
disease (10) 10
medicine, general & internal (10) 10
optical coherence tomography (10) 10
patients (10) 10
predictive value of tests (10) 10
predictors (10) 10
restenosis (10) 10
therapy (10) 10
acute coronary syndrome (9) 9
angioplasty, balloon, coronary - adverse effects (9) 9
bivalirudin (9) 9
cardiovascular agents - administration & dosage (9) 9
clinical outcomes (9) 9
clinical-outcomes (9) 9
coronary artery disease (9) 9
drug therapy (9) 9
follow-up (9) 9
intravascular ultrasound (9) 9
kaplan-meier estimate (9) 9
platelet aggregation inhibitors - administration & dosage (9) 9
platelet aggregation inhibitors - adverse effects (9) 9
proportional hazards models (9) 9
registry (9) 9
risk assessment (9) 9
stenosis (9) 9
surgery (9) 9
ultrasonography, interventional (9) 9
veins & arteries (9) 9
aspirin (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10059, pp. 2479 - 2491
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9962, pp. 43 - 54
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9784, pp. 2193 - 2204
Summary Background Primary results of the HORIZONS-AMI trial have been previously reported. In this final report, we aimed to assess 3-year outcomes. Methods... 
Internal Medicine | HARMONIZING OUTCOMES | MEDICINE, GENERAL & INTERNAL | BLOOD-TRANSFUSION | DOUBLE-BLIND | FOLLOW-UP | ACUTE CORONARY SYNDROMES | ST-SEGMENT ELEVATION | PREMATURE DISCONTINUATION | INTERVENTION | ANTIPLATELET THERAPY | CLINICAL-OUTCOMES | Confidence Intervals | Myocardial Infarction - mortality | Paclitaxel - pharmacology | Prospective Studies | Follow-Up Studies | Humans | Heparin - administration & dosage | Male | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Dose-Response Relationship, Drug | Myocardial Infarction - therapy | Platelet Glycoprotein GPIIb-IIIa Complex - administration & dosage | Time Factors | Electrocardiography | Female | Drug Therapy, Combination | Stents | Angioplasty, Balloon - methods | Myocardial Infarction - diagnosis | Drug-Eluting Stents | Drug Administration Schedule | Peptide Fragments - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Combined Modality Therapy | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Angioplasty, Balloon - mortality | Hirudins - adverse effects | Survival Analysis | Peptide Fragments - adverse effects | Bivalirudin | Research | Diagnosis | Heparin | Drug therapy | Comparative analysis | Health aspects | Heart attack | Heart attacks | Cardiology | Mortality
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9696, pp. 1149 - 1159
Summary Background In the HORIZONS-AMI trial, patients with acute ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | IMPACT | GLYCOPROTEIN IIB/IIIA BLOCKADE | BLOOD-TRANSFUSION | RISK | ACUTE CORONARY SYNDROMES | ACUITY TRIAL | ABCIXIMAB | INTERVENTION | ANTIPLATELET THERAPY | CLINICAL-OUTCOMES | Recombinant Proteins - therapeutic use | Myocardial Infarction - mortality | Follow-Up Studies | Humans | Middle Aged | Heparin - therapeutic use | Male | Recombinant Proteins - adverse effects | Heparin - adverse effects | Angioplasty, Balloon, Coronary - adverse effects | Aged, 80 and over | Adult | Female | Thrombosis - prevention & control | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Hemorrhage - epidemiology | Kaplan-Meier Estimate | Proportional Hazards Models | Anticoagulants - therapeutic use | Survival Rate | Treatment Outcome | Anticoagulants - adverse effects | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Myocardial Infarction - drug therapy | Thrombosis - etiology | Hirudins - adverse effects | Aged | Peptide Fragments - adverse effects | Peptide Fragments - therapeutic use | Hemorrhage - chemically induced | Stents - adverse effects | Care and treatment | Angioplasty | Patient outcomes | Bivalirudin | Dosage and administration | Health aspects | Heart attack | Clinical trials | Cardiovascular disease | Heart attacks | Drug therapy | Mortality
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 371, Issue 9612, pp. 559 - 568
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2008, Volume 51, Issue 5, pp. 538 - 545
Journal Article